Nashibi R - Search Results

1

Correlation of vitamin D levels with serum parameters in Covid-19 patients.

Beheshti M, Neisi N, Parsanahad M, Rasti M, Nashibi R, Cheraghian B. Beheshti M, et al. Among authors: nashibi r. Clin Nutr ESPEN. 2023 Jun;55:325-331. doi: 10.1016/j.clnesp.2023.04.012. Epub 2023 Apr 19. Clin Nutr ESPEN. 2023. PMID: 37202065 Free PMC article.

2

Human Rhinoviruses A9, A49, B14 and Echovirus 3, 9 among the patients with acute respiratory infection.

Pouremamali A, Makavndi M, Samarbafzadeh A, Neisi N, Rasti M, Shamsizadeh A, Teimoori A, Haj MS, Nashibi R, Salmanzadeh S, Nikfar R, Soleimani R, Shabani A. Pouremamali A, et al. Among authors: nashibi r. Epidemiol Mikrobiol Imunol. 2018 Spring;67(1):18-23. Epidemiol Mikrobiol Imunol. 2018. PMID: 30157660 Free article. English.

3

Prevalence of SARS-CoV-2 in Patients with Severe Pneumonia in Khuzestan Province, Iran.

Abolnezhadian F, Makvandi M, Alavi SM, Azaran A, Jalilian S, Rashno M, Kaydani GA, Arshadi M, Hosseinizadeh SM, Boostani H, Seyedian SS, Moogahi S, Salmanzadeh S, Varnaseri M, Neisi N, Keifarrokhi H, Shariati G, Amiri H, Parsanahad M, Nashibi R, Yousefi F, Ahmadi F, AhmadiAngali K. Abolnezhadian F, et al. Among authors: nashibi r. Iran J Allergy Asthma Immunol. 2020 Oct 18;19(5):471-477. doi: 10.18502/ijaai.v19i5.4462. Iran J Allergy Asthma Immunol. 2020. PMID: 33463114 Free article.

4

Antiinflammatory potential of nano-curcumin as an alternative therapeutic agent for the treatment of mild-to-moderate hospitalized COVID-19 patients in a placebo-controlled clinical trial.

Asadirad A, Nashibi R, Khodadadi A, Ghadiri AA, Sadeghi M, Aminian A, Dehnavi S. Asadirad A, et al. Among authors: nashibi r. Phytother Res. 2022 Feb;36(2):1023-1031. doi: 10.1002/ptr.7375. Epub 2022 Jan 17. Phytother Res. 2022. PMID: 35040210 Clinical Trial.

5

Tranilast as an Adjunctive Therapy in Hospitalized Patients with Severe COVID- 19: A Randomized Controlled Trial.

Saeedi-Boroujeni A, Nashibi R, Ghadiri AA, Nakajima M, Salmanzadeh S, Mahmoudian-Sani MR, Hanafi MG, Sharhani A, Khodadadi A. Saeedi-Boroujeni A, et al. Among authors: nashibi r. Arch Med Res. 2022 Jun;53(4):368-377. doi: 10.1016/j.arcmed.2022.03.002. Epub 2022 Mar 14. Arch Med Res. 2022. PMID: 35339280 Free PMC article. Clinical Trial.

6

Comparing the expression of MiR-223-NLRP3-IL-1β axis and serum IL-1β levels in patients with severe COVID-19 and healthy individuals.

Houshmandfar S, Khodadadi A, Mahmoudian-Sani MR, Nashibi R, Rashno M. Houshmandfar S, et al. Among authors: nashibi r. Immunobiology. 2023 Sep;228(5):152710. doi: 10.1016/j.imbio.2023.152710. Epub 2023 Jul 17. Immunobiology. 2023. PMID: 37478686

7

The therapeutic efficacy of quercetin in combination with antiviral drugs in hospitalized COVID-19 patients: A randomized controlled trial.

Shohan M, Nashibi R, Mahmoudian-Sani MR, Abolnezhadian F, Ghafourian M, Alavi SM, Sharhani A, Khodadadi A. Shohan M, et al. Among authors: nashibi r. Eur J Pharmacol. 2022 Jan 5;914:174615. doi: 10.1016/j.ejphar.2021.174615. Epub 2021 Dec 2. Eur J Pharmacol. 2022. PMID: 34863994 Free PMC article. Clinical Trial.

8

Serum mannan-binding lectin in patients with pulmonary tuberculosis: Its lack of a relationship to the disease and response to treatment.

Ahmadi F, Ghadiri A, NashibI R, Roozbeh F, Alizadeh-Navaei R. Ahmadi F, et al. Among authors: nashibi r. Med J Islam Repub Iran. 2017 Sep 30;31:66. doi: 10.14196/mjiri.31.66. eCollection 2017. Med J Islam Repub Iran. 2017. PMID: 29445695 Free PMC article.

9

Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19.

Saeedi-Boroujeni A, Mahmoudian-Sani MR, Nashibi R, Houshmandfar S, Tahmaseby Gandomkari S, Khodadadi A. Saeedi-Boroujeni A, et al. Among authors: nashibi r. Immunopharmacol Immunotoxicol. 2021 Jun;43(3):247-258. doi: 10.1080/08923973.2021.1925293. Epub 2021 May 21. Immunopharmacol Immunotoxicol. 2021. PMID: 34015982 Free PMC article. Review.

10

CT Characteristics of Coronavirus Disease 2019 Pneumonia and Its Association with C-Reactive Protein, Erythrocyte Sedimentation Rate and Gender.

Eftekhari Moghadam AR, Fazelinejad Z, Nashibi R, Pour MB. Eftekhari Moghadam AR, et al. Among authors: nashibi r. Adv Biomed Res. 2022 Jan 31;11:10. doi: 10.4103/abr.abr_33_21. eCollection 2022. Adv Biomed Res. 2022. PMID: 35284348 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters